Alsadik S, Gnanasegaran G, Chen L, Mandair D, et al. Safety of Peptide Receptor Radionuclide Therapy with (177)Lu-DOTATATE in Neuroendocrine Tumor Patients with Chronic Kidney Disease. J Nucl Med 2022;63:1503-1508.
PMID: 35210299